2. Antibody-drug Conjugate/ADC Related
  3. ADC Antibody
  4. Lorvotuzumab

Lorvotuzumab  (Synonyms: Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab))

Art. -Nr.: HY-P99372 Reinheit: 99.77%
COA
SDS
Technical Support

Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr. : 339306-30-8

Größe Preis Verfügbarkeit Menge
Kostenlose Probe (100 μg)   Jetzt bewerben  
1 mg Auf Lager
5 mg Auf Lager
10 mg Auf Lager
50 mg   Angebot einholen  
100 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Lorvotuzumab Related Antibodies

Top Publications Citing Use of Products

  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].

Isotype

Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity

Human
IC50 & Target

NCAM1/CD56
In Vitro

Lorvotuzumab mertansine (IMGN901) is an ADC that links a potent anti-mitotic (DM1) via a disulfide linker to CD56 targeting antibodies (Lorvotuzumab). Lorvotuzumab mertansine against Wilms tumor, rhabdomyosarcoma, and neuroblastoma[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Lorvotuzumab Related Antibodies
Klinische Studie
Gene ID

4684  [NCBI]

Accession
Application

ELISA, FACS, Functional assay
Conjugated

Unconjugated
Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.
Molekulargewicht

146.44 kDa

CAS. Nr.
Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Lorvotuzumab]
Versand

Shipping with dry ice.
Formulation

Please refer to the lot-specific COA for specific buffer information.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
Biological Activity
  • Immobilized NCAM-1/CD56 Protein, Human (HEK293, His, solution, HY-P75933) can bind Lorvotuzumab. The EC50 for this effect is 56.21 ng/mL.
  • Loaded Lorvotuzumab on AHC2 biosensor, can bind NCAM-1/CD56 Protein, Human (HEK293, His-Avi, HY-P75932) with an affinity constant of 3.918E-09 M as determined in BLI assay.
  • Flow Cytometry analysis of SK-N-SH cells with NCAM1/CD56 (red) with Lorvotuzumab (anti-NCAM1/CD56) (HY-P99372). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.
Reinheit & Dokumentation

Purity: 99.77%

SDS (252 KB)

COA (232 KB)

Inhibitory Antibodies User Guide (603 KB)
Verweise
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Lorvotuzumab Related Classifications

  • Molaritätsrechner

  • Verdünnungsrechner

Die Formel zur Berechnung von Molaritäten

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Lorvotuzumab339306-30-8Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)ADC AntibodyNCAM1CD56humanized monoclonal antibodyLorvotuzumab mertansineInhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

  

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

      

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
Lorvotuzumab
Art. -Nr.:
HY-P99372
Menge:
MCE Japan Authorized Agent:

Kundenbewertung

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Produktname

  

Lot #

Name des Antragstellers *

 

E-Mail-Addresse *

Telefonnummer

 

Department *

Name der Organisation *

 

Country or Region *

Bemerkungen

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.